AstraZeneca Drug Cocktail Succeeds in Late-Stage Study To Treat COVID-19
The British drugmaker also said that the experimental COVID-19 drug has helped in reducing the risk of death and severe disease. The drug, which is a mix of two antibodies, is both a preventative medicine and treatment for coronavirus.
AstraZeneca on Monday said that its experimental drug cocktail has succeeded in late-stage Study to treat COVID-19. The British drugmaker also said that the experimental COVID-19 drug has helped in reducing the risk of death and severe disease. The drug, which is a mix of two antibodies, is both a preventative medicine and treatment for coronavirus.
(SocialLY brings you all the latest breaking news, viral trends and information from social media world, including Twitter, Instagram and Youtube. The above post is embeded directly from the user's social media account and LatestLY Staff may not have modified or edited the content body. The views and facts appearing in the social media post do not reflect the opinions of LatestLY, also LatestLY does not assume any responsibility or liability for the same.)